Analysed FRESENIUS MEDICAL CARE-ADR (FMS:NYSE) News Sources
CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union
26-06-2026
yahoo.com
Fresenius Medical Care (XTRA:FME) Faces EU Setback After TAVNEOS Revocation Recommendation
28-06-2026
yahoo.com
Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy
20-07-2026
yahoo.com
Hikma and Fresenius best positioned from Trump's generic drug tariffs, says Citi
23-07-2026
proactiveinvestors.com
Quest Diagnostics Inc (DGX) Q2 2026 Earnings Call Highlights: Strong Revenue Growth Amid ...
23-07-2026
yahoo.com
What is the current price of FRESENIUS MEDICAL CARE-ADR (FMS:NYSE)?
The current price of FRESENIUS MEDICAL CARE-ADR (FMS:NYSE) is $24.86.
FRESENIUS MEDICAL CARE-ADR (FMS:NYSE) absolute price change since previous trading day?
The absolute price change of FRESENIUS MEDICAL CARE-ADR (FMS:NYSE) since the previous trading day is $0.11.
FRESENIUS MEDICAL CARE-ADR (FMS:NYSE) percentage price change since previous trading day?
The percentage price change of FRESENIUS MEDICAL CARE-ADR (FMS:NYSE) since the previous trading day is 0.4444%.
What is the most recent average sentiment score for FRESENIUS MEDICAL CARE-ADR (FMS:NYSE)?
The most recent average sentiment score for FRESENIUS MEDICAL CARE-ADR (FMS:NYSE) is 69 out of 100.
What is the most recent average sentiment for FRESENIUS MEDICAL CARE-ADR (FMS:NYSE)?
The most recent sentiment for FRESENIUS MEDICAL CARE-ADR (FMS:NYSE) is .
SEC-8K** Filing Available For FRESENIUS MEDICAL CARE-ADR (FMS:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.